No Data
Tonix Pharmaceuticals Presents Phase 3 Data On TNX-102 SL For Fibromyalgia At International Congress
WHO Maintains Public Health Emergency Alert on Mpox
Trump Floats 25% Tariffs on Autos, Chips, Pharmaceuticals
What's Going On With Tonix Pharmaceuticals Shares Friday?
Tonix Pharmaceutical Shares Are Trading Higher After the Company Provided Preliminary Q4 Financial Results.
Tonix Pharmaceuticals Reports FY24 Preliminary Financials: $98.8M In Cash And Cash Equivalents As Of December 31, 2024, Revenue Hits ~$10.1M Vs $7.8M YoY
